Anti-LXN Antibody | A1417

Hardly reversible, non-competitive, and potent inhibitor of CPA1, CPA2 and CPA4. May play a role in inflammation.

A1417 | Anti-LXN Antibody DataSheet

Antibody Target: LXN

Target Alternative Name: Latexin; Endogenous carboxypeptidase inhibitor; ECI; Protein MUM; Tissue carboxypeptidase inhibitor; TCI

Tag Line: Polyclonal Antibody to detect LXN in human samples

Category: Immunology

Host: Rabbit

Isotype: Rabbit IgG

Species Reactivities: Human, Mouse and Rat

Immunogen Sequence: KLH-conjugated synthetic peptide encompassing a sequence within the center region of LXN

Accession #: Q9BS40

Gene ID: Q64361

Appearance: Colorless liquid

Form: Liquid

Concentration:

Formulation: In 0.42% Potassium phosphate; 0.87% Sodium chloride; pH 7.3; 30% glycerol and 0.01% sodium azide

Purification: Affinity purified

Application: WB, IHC

Positive Control: WB: 22RV1; MCF7; HT29; BT474; mouse heart whole cell lysates.

Application And Usages: WB; 1:500 – 1:2000, IHC; 1:50 – 1:200

Country of Animal Origin: USA

Country of Manufacture: USA

Usage: For Research Use Only! Not to be used in humans.

Handling: The antibody solution should be gently mixed before use.

Western Blot Verified: Verified

Immunocytochemistry Verified: Verified

Immunofluorescence Verified: Not Verified

Immunoprecipitation Verified: Not Verified

FACS Verified: Not Verified

ELISA Verified: Not Verified

ChIP Verified: Not Verified

Dot Blot Verified: Not Verified

Flow Cytometry Verified: Not Verified